{"title": "Local tolerance study of the VA-MENGOC-BC\u00ae antimeningococcal vaccine in Sprague Dawley rats. Evaluation at 24 and 36 months of shelf", "author": "Reynaldo Oliva-Hern\u00c3ndez; Mildrey Fari\u00feas-Medina; Juan F Infante-Bourzac; Tamara Hern\u00c3ndez-Salazar; Darcy N\u00ba\u00feez-Mart\u00danez; Alex Quintero-P\u00d5rez; Concepci\u00b5n Campa-Huergo; Gustavo Sierra-Gonz\u00c3lez", "url": null, "hostname": null, "description": null, "sitename": "VacciMonitor", "date": "2002-01-01", "cleaned_text": "2019, Number 1 VacciMonitor 2019; 28 (1) Local tolerance study VA-MENGOC-BC\u00ae antimeningococcal vaccine in Sprague Dawley rats. Evaluation Meningococcal continues to be a health problem in different countries and different vaccines have been obtained for the prevention of this disease. VA-MENGOC-BC\u00db vaccine has been effective and safe in the prevention of meningococcal meningitis against serogroups B and C. This has shown good stability over time without changing its quality as a product; It was stored on a shelf for 24 and 36 months at temperatures of 4 to 8 \u00a4C. Their possible toxicological potential was evaluated Dawley rats. Immunized animals toxicity or deaths were observed. No differences were found between the experimental groups in terms of body weight, water and food consumption, no fever or local irritability evident. Anatomopathologically no lesions of that the VA-MENGOC-BC\u00db vaccine that remained on the shelf for 24 and 36 months did not show any local or systemic effects in rats. REFERENCES World Health Organization. Epidemic meningitis control in countries of the African meningitis belt. The Weekly Epidemiological Record. 2018;93(14):17384. Disponible en: http://www.who.int/wer. World Health Organization. [Homepage the internet]. Geneva: Developing a new generation Tests for 2018. Disponible en: http://www.who.int/emergencies/ Organization. [Homepage http://www.who.int/mediacentre/infographic/meningitis/en/. World Health evaluation of vaccine adjuvants and adjuvanted vaccine, Technical Report Series Geneva: 2013. on nonclinical vaccine. Technical Report and Toxicity Substances Applied Topically to the for Economic Cooperation and Development. Guideline for the Testing of Chemicals No 404. Paris: OECD; 2004. Disponible en: http://www.oecd.org/env/testguidelines . The National Academies Press. Guide for the care and use of laboratory animals. Eighth Edition. Washington: NAP; 2010. Disponible research: ethical, legal and practical aspect. Laboratory animals 2005;8:5-12. R Development Core Team. R: A language and environment for statistical computing. Vienna: GBIF; 2014. Disponible P\u00d5rez V, Argamasilla M, et al: Estudio de toxicidad por dosis \u00banica y tolerancia local de una vacuna antimeningoc\u00b5cica tipo B en ratas Sprague Dawley. Vaccimonitor 2006;15(2) Bourzac JF. VA-MENGOCBC en modelos La Habana: Universidad Agraria de la Habana; 2000. Fari\u00feas M, Oliva R, Infante JF, Valdez Y, Nu\u00feez D, Valmaceda T, et al. Ensayo piloto de inmunogenicidad y toxicidad precl\u00danica de la vacuna Salmonella R, Fern\u00c3ndez S, JF, Vald\u00d5s Y, Hern\u00c3ndez T, et al. Estudio de Toxicidad por Dosis \u00d6nica de la Vacuna Antimeningoc\u00b5ccica ACW135 internet]. Charles River Labs-Research en: http://www.taconic.com/rat-model/ sprague-dawley. Canadian Council on Animal Care. Guide to the care and use of experimental animals: Ottawa: CCAC; 1984. Ochoa RF, Bar\u00b5 IM, Men\u00d5ndez J, Triana T, Mirabal M, Armesto M, et al. Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tet\u00c3nico y dift\u00d5rico con concentraci\u00b5n reducida en adolescentes cubanos. VacciMonitor 2006;15(2):13-7. Garc\u00daa HM, Thompson R, Valera R, Fando R, Fumane J, Mirabal M, et al. A single dose of live-attenuated 638 Vibrio cholerae oral vaccine is Harmsen MC. Ethical Issues in the Use of Animal Models for Tissue Engineering: Reflections on Legal Aspects, Moral Theory, Three Rs Strategies, and HarmBenefit Analysis. Tissue Engineering Part C: Methods. 2017;23(12):850-62. Organization for Economic Cooperation and Development. Test No 439, In Vitro Skin Irritation, "}